Medical Journals

Regulation of Osteoclastogenesis by Gap Junction Communication.

Authors:
  • Matemba Stephen F
  • Lie Anita
  • Ransjö Maria

From: Department of Odontology, Division of Oral Cell Biology, Umeå University, SE 901 87, Umeå, Sweden.

Journal of cellular biochemistry

  • Publish Date: Oct 2006
  • ISSN: 0730-2312
  • Volume: 99
  • Issue: 2
  • Pages: 528-37
  • Medium: Print
  • Language: English
  • Citation (JAMA): Matemba Stephen F, Lie Anita, Ransjö Maria, et al. Regulation of Osteoclastogenesis by Gap Junction Communication.. J. Cell. Biochem. Oct 2006;99:528-37

Abstract

Receptor activator of NF-kappaB ligand (RANKL) is crucial in osteoclastogenesis but signaling events involved in osteoclast differentiation are far from complete and other signals may play a role in osteoclastogenesis. A more direct pathway for cellular crosstalk is provided by gap junction intercellular channel, which allows adjacent cells to exchange second messengers, ions, and cellular metabolites. Here we have investigated the role of gap junction communication in osteoclastogenesis in mouse bone marrow cultures. Immunoreactive sites for the gap junction protein connexin 43 (Cx43) were detected in the marrow stromal cells and in mature osteoclasts. Carbenoxolone (CBX) functionally blocked gap junction communication as demonstrated by a scrape loading Lucifer Yellow dye transfer technique. CBX caused a dose-dependent inhibition (significant > or = 90 microM) of the number of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells formed in 7- to 8-day marrow cultures stimulated by parathyroid hormone (PTH; 10 nM) or forskolin (FSK; 1 microM). Furthermore, CBX (100 microM) significantly inhibited prostaglandin E2 (PGE2; 10 microM) and 1,25(OH)2-vitamin D3 stimulated osteoclast differentiation in the mouse bone marrow cultures. Consequently, quantitative real-time polymerase chain reaction (PCR) analysis demonstrated that CBX downregulated the expression of osteoclast phenotypic markers, but without having any significant effects on RANK, RANKL, and osteoprotegerin (OPG) mRNA expression. However, the results demonstrated that CBX significantly inhibits RANKL-stimulated (100 ng/ml) osteoclastogenesis in the mouse bone marrow cultures. Taken together, our results suggests that gap junctional diffusion of messenger molecules interacts with signaling pathways downstream RANKL in osteoclast differentiation. Further studies are required to define the precise mechanisms and molecular targets involved.

Mesh Headings (Keywords): Animals, Base Sequence, Bone Resorption, Calcitriol, Carbenoxolone, Carrier Proteins, Cell Communication, Cell Differentiation, Cells, Cultured, Connexin 43, DNA, Complementary, Dinoprostone, Forskolin, Gap Junctions, Glycoproteins, Membrane Glycoproteins, Mice, Osteoclasts, Osteoprotegerin, Parathyroid Hormone, RANK Ligand, RNA, Messenger, Receptor Activator of Nuclear Factor-kappa B, Receptors, Cytoplasmic and Nuclear, Receptors, Tumor Necrosis Factor, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 16639710


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.